158 filings
Page 3 of 8
8-K
1huwsverjxq5m 69
9 Jan 23
January 2023 Corporate Presentation
8:01am
8-K
vgnmda
6 Jan 23
Entry into a Material Definitive Agreement
4:06pm
8-K
ur04ibf
12 Dec 22
Other Events
4:03pm
424B5
6fna1kdei
12 Dec 22
Prospectus supplement for primary offering
4:02pm
8-K
x7pja3 he62c
12 Dec 22
Other Events
10:01am
8-K
i6ri7qiac74tecc
22 Nov 22
Keros Therapeutics to Present at Upcoming Healthcare Conferences
8:02am
8-K
v3kj52
7 Nov 22
Keros Therapeutics Presents Preclinical Data from its KER-012 Program at the American Heart Association 2022 Scientific Sessions
4:07pm
8-K
a2c27
3 Nov 22
Other Events
9:02am
8-K
vbh39kj
3 Nov 22
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:01am
8-K
fmoa 6vztrqxs
12 Sep 22
Other Events
6:03am
8-K
cfx5gb5 pyec45v3j
6 Sep 22
Keros Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
8:05am
8-K
pzj5i8t9t3cfti8f32
4 Aug 22
August 2022 Corporate Presentation
5:13pm
8-K
vlr529v
4 Aug 22
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results
4:09pm
8-K
e8q3lf0
13 Jun 22
Other Events
8:01am
8-K
z67pyjrh0k30yjeq2
10 Jun 22
Other Events
6:03am
8-K
uxylbu0i
1 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
05ghcry0
18 May 22
Keros Therapeutics Announces Preliminary Topline Results from its Ongoing Phase 1 Clinical Trial Evaluating KER-012 in Healthy Volunteers
6:12am
8-K
38bo58
17 May 22
Other Events
4:05pm